查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1751196

药局市场规模、份额、趋势分析报告：按产品类型、地区、细分市场预测，2025-2030 年

Pharmacy Market Size, Share & Trends Analysis Report By Product (Prescription, OTC), By Type (Hospital Pharmacy, Retail Pharmacy (Chain, Independent, Others), ePharmacy, Others), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 142 Pages | 商品交期: 2-10个工作天内

价格

药房市场的成长和趋势：

根据 Grand View Research, Inc. 的最新报告，预计到 2030 年全球药局市场规模将达到 2.6 兆美元，预测期内的复合年增长率为 7.3%。

成长主要得益于慢性病盛行率的上升、网路药局服务市场渗透率的提高以及全球零售商进入市场。

主要市场参与企业区域影响力，企业之间建立联盟，以及日益普及的便利且节省成本的线上药局服务，预计将进一步推动该市场的成长。不良事件发生率的上升导致成药需求增加，处方药市场的成长（主要得益于诊断和影像技术的进步），这些因素很可能在预测期内带来巨大的成长机会。

用于增强流程和服务交付的先进技术的开发、为製药行业参与企业开发的各种软体解决方案的可用性以及促进电子药房服务增长的智慧型手机设备的广泛使用也促进了该市场的发展。主要企业之间的合作、线上药局不断扩大的数位足迹以及许多专注于加强全球影响力的市场参与企业也在影响着这个市场。

药房市场报告重点

  • 从产品来看，由于癌症、糖尿病和心血管疾病等慢性疾病的增加，处方笺部分将主导全球製药业，到 2024 年将占 80% 以上的收入份额。
  • 预计预测期内 OTC 市场将成长最快。
  • 零售药局部门占据了药局产业最大的收益占有率，这得益于几家全球零售公司进入药局业务、主要企业经营的庞大零售药局网路以及网路零售药局的成长。
  • 预计在预测期内，电子药局领域将经历最快的成长。
  • 北美在全球製药业占据主导地位，2024 年的收益占有率将超过 50%。这归功于在该地区运营的多家製药公司以及在多个地点提供服务的大型零售药局连锁店，尤其是在美国。

目录

第一章调查方法与范围

第二章执行摘要

第三章 药局市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 药局市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章 药局市场：产品评估与趋势分析

  • 产品细分仪表板
  • 医药市场：产品趋势分析
  • 全球药局市场规模及趋势分析（依产品，2018-2030）
  • 处方
  • OTC

第五章 药局市场：类型评估与趋势分析

  • 类型细分仪表板
  • 药局市场：类型变化分析
  • 全球药局市场规模及趋势分析（按类型，2018-2030）
  • 医院药房
  • 零售药局
    • 链
    • 独立
    • 其他的
  • 网路药局
  • 其他的

第六章 药局市场：区域估计与趋势分析

  • 区域市场仪表板
  • 2024 年及 2030 年区域市场占有率分析
  • 各地区连续生物加工市场：关键要点
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
  • 公司简介
    • CVS Health
    • Boots Walgreens
    • Walmart Inc.
    • The Kroger Co.
    • Rite Aid Corp.
    • MCKESSON CORPORATION
    • Well Pharmacy
    • Humana
    • Matsumotokiyoshi Co., Ltd.
    • Apollo Pharmacy
    • MedPlusMart.com
    • Amazon
Product Code: GVR-4-68039-701-1

Pharmacy Market Growth & Trends:

The global pharmacy market size is anticipated to reach USD 2.06 trillion by 2030 and is anticipated to expand at a CAGR of 7.3% during the forecast period, according to a new report by Grand View Research, Inc. The rising prevalence of chronic diseases, increasing market penetration of online pharmacy services, and the entry of global retail companies into this market are primarily driving the growth.

Increasing investments by key market participants in improving presence across various regions, collaborations among companies, and rising adoption of online pharmacy services that offer convenience and cost savings are expected to fuel further growth of this market. The growing incident rate of accidents leading to higher demand for OTC drugs and the growth experienced by the prescription medicine segment, primarily due to enhanced diagnostic technologies and imaging techniques, are likely to develop strong growth opportunities over the forecast period.

Adoption of advanced technologies for enhanced processes and service delivery, availability of various software solutions developed for pharmacy industry participants, and increasing ubiquity of smartphone devices, which facilitates the growth of ePharmacy services, also contribute to the advancements experienced by this market. Collaborations among key companies, the growing digital footprint of online pharmacies, and the focus of numerous key market participants on enhancing global presence also influence this market.

Pharmacy Market Report Highlights:

  • On the basis of products, the prescription segment dominated the global pharmacy industry and accounted for over 80% of the revenue share in 2024, owing to the rising occurrence of chronic illnesses such as cancer, diabetes, and cardiovascular diseases.
  • The OTC segment is projected to experience the fastest growth over the forecast period.
  • The retail pharmacy segment held the largest revenue share of the pharmacy industry, owing to the entry of multiple global retail companies in the pharmacy business, a vast network of retail pharmacy stores operated by key players, and the growth experienced by online retail pharmacy.
  • The ePharmacy segment is anticipated to experience the fastest growth over the forecast period.
  • North America dominated the global pharmacy industry with a revenue share of more than 50% in 2024, owing to various pharmaceutical manufacturing companies operating in the region and large retail pharmacy chains providing services across multiple locations, especially in the U.S.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product segment
    • 1.2.2. Type segment
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Type outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Pharmacy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Pharmacy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis

Chapter 4. Pharmacy Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Pharmacy Market: Product Movement Analysis
  • 4.3. Global Pharmacy Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Prescription
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. OTC
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Pharmacy Market: Type Estimates & Trend Analysis

  • 5.1. Type Segment Dashboard
  • 5.2. Pharmacy Market: Type Movement Analysis
  • 5.3. Global Pharmacy Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. Hospital Pharmacy
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Retail Pharmacy
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Chain
      • 5.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. Independent
      • 5.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. ePharmacy
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Pharmacy Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Continuous bioprocessing market by Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Norway
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework/ reimbursement structure
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Australia
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Argentina
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. South Africa
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. UAE
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.4. Kuwait
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Regulatory framework/ reimbursement structure
      • 6.8.4.3. Competitive scenario
      • 6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. CVS Health
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Boots Walgreens
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Walmart Inc.
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. The Kroger Co.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Rite Aid Corp.
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. MCKESSON CORPORATION
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Well Pharmacy
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Humana
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Matsumotokiyoshi Co., Ltd.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Apollo Pharmacy
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. MedPlusMart.com
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Amazon
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global pharmacy market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 5 North America pharmacy market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 7 North America pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 12 Mexico pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 14 Europe pharmacy market, by country, 2018 - 2030 (USD Million)
  • Table 15 Europe pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 16 Europe pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 17 Germany pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 18 Germany pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 19 UK pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 21 France pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 22 France pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 23 Italy pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 24 Italy pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 25 Spain pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 26 Spain pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 27 Denmark pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 28 Denmark pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 29 Sweden pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 30 Sweden pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 31 Norway pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 32 Norway pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific pharmacy market, by country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 36 China pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 37 China pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 38 Japan pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 39 Japan pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 40 India pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 41 India pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 42 South Korea pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 43 South Korea pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 44 Australia pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 45 Australia pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 46 Thailand pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 47 Thailand pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 48 Latin America pharmacy market, by country, 2018 - 2030 (USD Million)
  • Table 49 Latin America pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 50 Latin America pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 51 Latin America pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 52 Brazil pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 53 Brazil pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 54 Argentina pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 55 Argentina pharmacy on market, by type, 2018 - 2030 (USD Million)
  • Table 56 MEA pharmacy market, by region, 2018 - 2030 (USD Million)
  • Table 57 MEA pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 58 MEA pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 59 South Africa pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 60 South Africa pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 63 UAE pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 64 UAE pharmacy market, by type, 2018 - 2030 (USD Million)
  • Table 65 Kuwait pharmacy market, by product, 2018 - 2030 (USD Million)
  • Table 66 Kuwait pharmacy market, by type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Pharmacy market: Market outlook
  • Fig. 10 Pharmacy competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Pharmacy market driver impact
  • Fig. 16 Pharmacy market restraint impact
  • Fig. 17 Pharmacy market strategic initiatives analysis
  • Fig. 18 Pharmacy market: Product movement analysis
  • Fig. 19 Pharmacy market: Product outlook and key takeaways
  • Fig. 20 Prescription products market estimates and forecast, 2018 - 2030
  • Fig. 21 OTC products market estimates and forecast, 2018 - 2030
  • Fig. 22 Pharmacy market: Type movement Analysis
  • Fig. 23 Pharmacy market: Type outlook and key takeaways
  • Fig. 24 Hospital pharmacy market estimates and forecasts, 2018 - 2030
  • Fig. 25 Retail pharmacy market estimates and forecasts, 2018 - 2030
  • Fig. 26 Chain retail pharmacy market estimates and forecasts, 2018 - 2030
  • Fig. 27 Independent retail pharmacy market estimates and forecasts, 2018 - 2030
  • Fig. 28 Other retail pharmacies market estimates and forecasts, 2018 - 2030
  • Fig. 29 epharmacy market estimates and forecasts, 2018 - 2030
  • Fig. 30 Other pharmacy market estimates and forecasts, 2018 - 2030
  • Fig. 31 Global pharmacy market: Regional movement analysis
  • Fig. 32 Global pharmacy market: Regional outlook and key takeaways
  • Fig. 33 North America market estimates and forecasts, 2018 - 2030
  • Fig. 34 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 35 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 36 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 37 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 38 UK market estimates and forecasts, 2018 - 2030
  • Fig. 39 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 40 France market estimates and forecasts, 2018 - 2030
  • Fig. 41 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 42 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 43 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 44 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 45 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 46 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 47 China market estimates and forecasts, 2018 - 2030
  • Fig. 48 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 49 India market estimates and forecasts, 2018 - 2030
  • Fig. 50 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 51 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 52 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 53 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 54 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 55 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 56 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 57 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 59 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 60 Kuwait market estimates and forecasts, 2018 - 2030